ACU-TENS on Pain and Stress Reduction Before and During TUGOR
Acupuncture-type Transcutaneous Electrical Nerve Stimulation on Pain and Stress Reduction Before and During Transvaginal Ultrasound-guided Oocyte Retrieval: a Randomized Controlled Trial
1 other identifier
interventional
144
1 country
1
Brief Summary
Objectives: To demonstrate the use of acupuncture-type transcutaneous electrical nerve stimulation (acu-TENS) during transvaginal ultrasound-guided oocyte retrieval (TUGOR) will reduce 50% of the intensity of pain experienced by women. Hypothesis to be tested: Does the use of acu-TENS reduce 50% of pain in TUGOR? Design and subjects: A prospective randomized control trial will be carried out at the Department of Obstetrics and Gynaecology, Prince of Wales Hospital. 144 women undergoing TUGOR will be randomized to receive acu-TENS or sham acu-TENS for pain control during TUGOR. Study instruments: During the TUGOR procedure, ultrasound of the pelvis will be performed by Aloka ProSound SSD-3500SX device (Japan). Each follicle will be pierced using a single lumen ovum aspiration needle or a double lumen ovum aspiration catheter (COOK Medical, UK) under ultrasound guidance. Acu-TENS will be done using MTR+ Myolito Multifunctional Stimulator. Main outcome measures: Primary outcome is the pain score before and during TUGOR. Secondary outcomes include (1) other pain level parameters including pain control satisfaction, surgeon's assessment of the patient co-operation score and patient intraoperative pain; (2) stress and anxiety levels, Stait Trait Anxiety Inventory, General Health Questionnaire, Beck Depression Inventory, and saliva cortisol; (3) patient's satisfaction measured by Client Satisfaction Questionnaire and satisfaction score on pain control; (4) difficulty in retrieving oocytes; (5) IVF parameters; (6) safety profile; and (7) bias assessment. Data analysis: Data analysis will be performed using Statistical Packages of Social Sciences for Windows. Expected results: The investigators expect that acu-TENS will reduce 50% of pain in TUGOR.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2025
CompletedFirst Posted
Study publicly available on registry
April 4, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
December 22, 2025
December 1, 2025
2.3 years
March 26, 2025
December 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain VAS (minimum 0 to maximum 100)
Research assistance who is not involved in the TUGOR will ask patients about the pain level by a ruler on 100mm visual analogous scale (VAS; 0 mm = no pain, 100mm = worst pain). Before operation, patient will be asked to give VAS pain and anxiety before admission and 1 hour before TUGOR. This is to assess the baseline pain perception for the patients. VAS for vaginal and abdominal pain and will be rated by patient when the surgeon switch to contra-lateral ovary and shortly after TUGOR. Patient will be asked to rate the abdominal and vaginal pain again 30 minutes, 1 hour, 2 hours, and 4 hours after TUGOR (before discharge). With a change of more than or equal to 10 for the 100 mm VAS, the analgesic intervention is clinical important.
Before admission and 1 hour before TUGOR, when switch to contra-lateral ovary, shortly after TUGOR, and 30 minutes, 1 hour, 2 hours, and 4 hours after TUGOR
Secondary Outcomes (9)
Satisfaction score (minimum 0 to maximum 100)
4 hour after TUGOR
Patient compliance index (minimum 1 to maximum 5)
4 hour after TUGOR
Patient pain score (minimum 0 to maximum 4)
4 hour after TUGOR
Additional use of analgesia
4 hour after TUGOR
Spielberger's State Anxiety Inventory (minimum 20 to maximum 80)
Before admission and 1 hour after TUGOR
- +4 more secondary outcomes
Study Arms (2)
Acu-TENS
EXPERIMENTALAcu-TENS treatment
Sham acu-TENS
SHAM COMPARATORSham acu-TENS without electric current
Interventions
This protocol makes use of the acu-TENS treatment on the acupoints Hegu (LI4), Zusanli (ST36), Sanyinjiao (SP6), and Taichong (LR3). After cleaning the acupoints with alcohol, electrode pads (HC-ROUND-32 2.0) will be placed on the acupoints according to the locations described in the Standard International Acupuncture Nomenclature. The electrode pads will be connected to a TENS machine (MTR+ Myolito Multifunctional Stimulator MTRP-00003), in which ipsilateral LI4 and SP36, SP6 and LR3 serve a pair. A pulse rate of 120 Hz, current of 3-5 mA, and pulse width of 300µS will be delivered continually during TUGOR.
In the sham acu-TENS, within the same time interval, TENS pads will be placed on the same acupoints, connected to the machine, but without electric current.
Eligibility Criteria
You may qualify if:
- Women undergoing IVF-ET cycles are to be recruited from the Assisted Reproduction Technology unit in the Prince of Wales Hospital
You may not qualify if:
- Patient not eligible for acu-TENS
- Patient with severe cardiac and respiratory disease history
- Smoker or drinker
- Refuse or incompetence for informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chung Pui Wah, Jacqueline
Hong Kong, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor (Clinical)
Study Record Dates
First Submitted
March 26, 2025
First Posted
April 4, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2028
Last Updated
December 22, 2025
Record last verified: 2025-12